Kolexia
Costello Regis Hématologie
Costello Regis
Hématologie
Hôpital La Conception
Marseille, France
181 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Lymphome B Myélome multiple Tumeurs hématologiques Maladie de Hodgkin Lymphome B diffus à grandes cellules

Collaborateurs

Voir plus
Farnault Laure
Farnault Laure
Hôpital La Conception, Marseille, France
Venton Geoffroy
Venton Geoffroy
Hôpital La Conception, Marseille, France
Ivanov Vadim
Ivanov Vadim
Hôpital La Conception, Marseille, France
Mercier Cedric
Mercier Cedric
Hôpital La Conception, Marseille, France

Industries

Voir plus
A+A
46 collaboration(s)
Dernière en 2023
B3TSI
16 collaboration(s)
Dernière en 2023
Sanofi
13 collaboration(s)
Dernière en 2023
Novartis
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Tamibarotene Plus Azacitidine Versus Placebo Plus Azacitidine in Newly Diagnosed, Adult Patients Selected for RARA-positive Higher-risk Myelodysplastic Syndrome (SELECT MDS-1)
Essai Clinique (Syros Pharmaceuticals)   11 mars 2024
Umbilical Cord Blood Transplantation for Fanconi Anemia with a special focus on late complications: a Study on Behalf of Eurocord and SAAWP-EBMT.
Transplantation and cellular therapy   05 mars 2024
Correction: Efficient pathway for men fertility preservation in testicular cancer or lymphoma: a cross-sectional study of national 2018 data.
Basic and clinical andrology   05 février 2024
High Complete Metabolic Response Rates with Epcoritamab SC + GemOx in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for Autologous Stem Cell Transplant: Updated Results from Epcore NHL-2
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
ALFA2101: An ALFA 2101 Multicenter Randomized Phase II Study: CPX-351 Versus Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
Essai Clinique (CHU Nice)   29 janvier 2024
Single-Cell Transcriptome Analysis of Acute Myeloid Leukemia Cells Using Methanol Fixation and Cryopreservation.
Diseases (Basel, Switzerland)   20 décembre 2023
Efficient pathway for men fertility preservation in testicular cancer or lymphoma: a cross-sectional study of national 2018 data.
Basic and clinical andrology   12 décembre 2023
AGORA-1 /ALFA 2100 Study : A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD Relapse/Refractory (R/R) AML
Essai Clinique (Centre Antoine Lacassagne)   09 novembre 2023
MYELOME-MM: Immunophenotyping of Plasma Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From Multiple Myeloma (MM) Patients
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   06 novembre 2023
Epcoritamab SC + GemOx Leads to High Complete Metabolic Response Rates in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for Autologous Stem Cell Transplant: Updated Results from Epcore NHL-2
65th ASH Annual Meeting Abstracts   02 novembre 2023